Blog

Optimizing Fill-Finish for Biologics: From Development to commercial readiness 

Optimizing fill–finish for biologics begins at a point where resources are constrained, knowledge is incomplete, and regulatory scrutiny is intense. The central task is to convert a promising molecule into a phase-appropriate, manufacturable dosage form that is safe, stable, and clinically usable—often […]

First-Time Developments Without the First-Time Risk: Protecting Your Asset’s Valuation 

In the high-stakes world of small-molecule development, the transition from pre-clinical “garage-style” synthesis to a scalable, GMP-ready clinical candidate is where most asset valuations either soar or plummet. For small and mid-sized pharma companies, this is not just a technical hurdle, it is a […]

Engineering a Foundation of Trust: The Kawagoe Approach to Security and Compliance

In the highly regulated world of pharmaceutical manufacturing, the production of controlled substances represents a pinnacle of complexity. The process demands that requirements for quality, safety, operability, regulatory compliance, and security are all satisfied simultaneously. This unyielding standard necessitates an […]

The “First Time Right” Imperative: Why Feasibility is the Basis of Aseptic Fill-Finish

In the high-stakes world of aseptic manufacturing, the distance between a successful batch and a multi-million-euro “atypical finding” is often measured in millimeters—the diameter of a tubing line, the viscosity of a bulk solution, or the precise pressure of a […]

GMP Compliance in Action: The Power of Validated Analytical Methods

In the world of manufacturing, consistency is paramount. Every product manufactured must consistently meet precise specifications. This unyielding standard is especially critical within the pharmaceutical industry, where the direct impact on patient safety necessitates extraordinarily rigorous oversight. Regulatory bodies worldwide, […]

Supporting Projects from Generics to Complex Formulations 

At our Athens site, versatility is our strength. For decades, our team has been a trusted partner in generic drug development. But today, we also help bring some of the most complex pharmaceutical projects to life.  From value-added medicines to […]

Subscribe to our newsletter!

Get notified on our latest news.